but shocking figures uncovered by labour yesterday show some patients are suffering agonising waits of as many as 541 days to begin treatment...
daily pilot..
.. .
.
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6..: "fremanezumab for the preventive treatment of chronic migraine.".
crispr therapeutics, mgh team up on new cancer treatments.
treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk..
.